BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya

FDA inspection history in Bangalore, India, 2020

1
Form 483

Every document, by year

  • Form 483

2020: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2020One Form 483, at Bangalore, India.

Cited most

Across all BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya observations on file

  • 21 CFR 211.84
    Testing and approval or rejection of components, drug product containers, and closures
    1

The complete BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya file.

All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.

$99

The documents one by one, while the file is prepared

See the documents

Sites

Documents

1 on file, newest first
DateDocumentPrice
2020-02-07483 Form 483$99

Investigators on these documents

Saied A. Asbagh (1)

About BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya

How many FDA Form 483s has BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya received?

FDA Intel has 1 Form 483 on file for BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya; the most recent is dated Feb 7, 2020.

When was BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya last inspected by FDA?

The most recent FDA inspection document on file for BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya is a Form 483 dated Feb 7, 2020, for the site in Bangalore, India.

What did FDA cite at BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya?

The regulations cited most in the observations on file for BioMylz Pvt. Ltd. Building No. 1, #21-D, 2nd Phase, Peenya are 21 CFR 211.84 (Testing and approval or rejection of components, drug product containers, and closures), 1 time.